Selective drug design models struggle to avoid off-target effects
On the Selectivity of Generative Models in Structure-Based Drug Design
Machine LearningArtificial Intelligence
Summary
Designing drugs that stick only to the intended proteins without bothering others is important to reduce side effects. The authors created SELECTBENCH, a new way to test how well computer programs can design such selective drugs by looking at multiple real-life situations. They tested several existing programs, including some designed to focus on selectivity, and found that these models still have a hard time avoiding unwanted interactions. This work highlights where current tools fall short and offers a shared platform to help improve future drug design programs.
What this means in practice
- •For pharmaceutical development teams: Use SELECTBENCH to evaluate and improve drug design models for reducing unwanted protein interactions during safety screening.
- •For biotech software developers: Incorporate SELECTBENCH in development cycles to benchmark generative models focused on selective drug molecule creation.
Authors
Ella Miray Rajaonson, Jungyoon Lee, William Chau, Alan Aspuru-Guzik, Benjamin Sanchez-Lengeling, Dominique Beaini, Kirill Neklyudov, Marta Skreta
Abstract
Designing small-molecule drugs that selectively bind to a target protein while avoiding unintended interactions with other proteins is essential for reducing side effects that contribute substantially to clinical attrition. Although structure-based drug design (SBDD) has advanced rapidly with deep learning, most generative models still optimize binding to a single target and disregard selectivity due to limited training data and unknown off-target interactions. Motivated by this gap, we introduce SELECTBENCH, a comprehensive benchmark assessing the selectivity of generative SBDD models. SELECTBENCH provides three curated evaluation tasks reflecting different real-world drug discovery scenarios: literature-based case studies, safety screening panels used in pharmaceutical development, and large-scale structure-based evaluation sets. We further introduce a suite of metrics to quantify selectivity and conduct a systematic evaluation of nine representative SBDD models, including methods explicitly trained for selectivity and widely-used inference-time guidance techniques. Our results show that even selectivity-trained models achieve only modest off-target discrimination and inference-time guidance provides limited gains, underscoring the need for method improvement. SELECTBENCH provides both a characterization of where current generative SBDD stands on selectivity and an open, extensible platform to accelerate progress. The benchmark is available at https://github.com/lovetaro/selectbench.